EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic study of tissue factor expression in solid tumors

Johann S de Bono iD, Jeffrey R Harris, Saskia M Burm, Adriaan Vanderstichele, Mischa A Houtkamp, Saida Aarass, Ruth Riisnaes, Ines Figueiredo, Daniel Nava Rodrigues, Rossitza Christova, Siel Olbrecht, Hans W M Niessen und 5 weitere

Cancer Reports · 2023-02 · 6 (2)

DOI: 10.1002/cnr2.1699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, online erschienen am 13.08.2022. Verfasst von Johann S de Bono und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Institute of Cancer Research, Royal Cancer Hospital, London, UK. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Glioblastoma, Head and Neck Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Elevated tissue factor (TF) expression, although restricted in normal tissue, has been reported in multiple solid cancers, and expression has been associated with poor prognosis. This manuscript compares TF expression across various solid tumor types via immunohistochemistry in a single study, which has not been performed previously.

Aims

To increase insight in the prevalence and cellular localization of TF expression across solid cancer types, we performed a detailed and systematic analysis of TF expression in tumor tissue obtained from patients with ovarian, esophageal, bladder, cervical, endometrial, pancreatic, prostate, colon, breast, non‐small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), and glioblastoma. The spatial and temporal variation of TF expression was analyzed over time and upon disease progression in patient‐matched biopsies taken at different timepoints. In addition, TF expression in patient‐matched primary tumor and metastatic lesions was also analyzed. Methods and Results TF expression was detected via immunohistochemistry (IHC) using a validated TF‐specific antibody. TF was expressed in all cancer types tested, with highest prevalence in pancreatic cancer, cervical cancer, colon cancer, glioblastoma, HNSCC, and NSCLC, and lowest in breast cancer. Staining was predominantly membranous in pancreatic, cervical, and HNSCC, and cytoplasmic in glioblastoma and bladder cancer. In general, expression was consistent between biopsies obtained from the same patient over time, although variability was observed for individual patients. NSCLC biopsies of primary tumor and matched lymph node metastases showed no clear difference in TF expression overall, although individual patient changes were observed.

Conclusion

This study shows that TF is expressed across a broad range of solid cancer types, and expression is present upon tumor dissemination and over the course of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsGlioblastomaHead and Neck NeoplasmsMaleFemaleHumansSquamous Cell Carcinoma of Head and NeckThromboplastin

Stichwörter der Autor:innen

biopsies expressionimmunohistochemistrysolid tumortargeted therapytissue factor

Substanzen

Thromboplastin

Autor:innen und Institutionen

  • The Institute of Cancer Research, Royal Cancer Hospital, London, UK.
  • Genmab, Plainsboro, New Jersey, USA.
  • Genmab, Utrecht, The Netherlands.
  • Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Department of Pathology, VU Medical Center, Amsterdam, The Netherlands.
  • Lava Therapeutics, Utrecht, The Netherlands.

ORCID-Profile: Johann S de Bono

Zitieren

APA

de Bono, J. S., Harris, J. R., Burm, S. M., Vanderstichele, A., Houtkamp, M. A., Aarass, S., Riisnaes, R., Figueiredo, I., Nava Rodrigues, D., Christova, R., Olbrecht, S., Niessen, H. W. M., Ruuls, S. R., Schuurhuis, D. H., Lammerts van Bueren, J. J., Breij, E. C. W., & Vergote, I. (2023). Systematic study of tissue factor expression in solid tumors. Cancer Reports, 6(2). https://doi.org/10.1002/cnr2.1699

Vancouver

de Bono JS, Harris JR, Burm SM, Vanderstichele A, Houtkamp MA, Aarass S, et al. Systematic study of tissue factor expression in solid tumors. Cancer Reports. 2023;6(2). doi:10.1002/cnr2.1699

BibTeX
@article{deBono2023,
  author = {de Bono, Johann S and Harris, Jeffrey R and Burm, Saskia M and Vanderstichele, Adriaan and Houtkamp, Mischa A and Aarass, Saida and Riisnaes, Ruth and Figueiredo, Ines and Nava Rodrigues, Daniel and Christova, Rossitza and Olbrecht, Siel and Niessen, Hans W M and Ruuls, Sigrid R and Schuurhuis, Danita H and Lammerts van Bueren, Jeroen J and Breij, Esther C W and Vergote, Ignace},
  title = {Systematic study of tissue factor expression in solid tumors},
  journal = {Cancer Reports},
  year = {2023},
  volume = {6},
  number = {2},
  doi = {10.1002/cnr2.1699}
}
Kostenlos starten →